John P. Hamill

2023 - Aprea Therapeutics

In 2023, John P. Hamill earned a total compensation of $908.4K as Chief Financial Officer at Aprea Therapeutics.

Compensation breakdown

Non-Equity Incentive Plan$189,340
Option Awards$197,275
Salary$387,917
Stock Awards$133,851
Total$908,383

Hamill received $387.9K in salary, accounting for 43% of the total pay in 2023.

Hamill also received $189.3K in non-equity incentive plan, $197.3K in option awards and $133.9K in stock awards.

Rankings

In 2023, John P. Hamill's compensation ranked 1,315th out of 2,983 executives tracked by ExecPay. In other words, Hamill earned more than 55.9% of executives.

ClassificationRankingPercentile
All
1,315
out of 2,983
56th
Division
Manufacturing
787
out of 1,637
52nd
Major group
Chemicals And Allied Products
521
out of 906
43rd
Industry group
Drugs
508
out of 869
42nd
Industry
Pharmaceutical Preparations
353
out of 627
44th
Source: SEC filing on April 25, 2024.

Hamill's colleagues

We found two more compensation records of executives who worked with John P. Hamill at Aprea Therapeutics in 2023.

2023

Oren Gilad

Aprea Therapeutics

Chief Executive Officer

2023

Scott Coiante

Aprea Therapeutics

Chief Financial Officer

News

You may also like